[1]
J. Bussaban, “Factors Associated with Changing the Low-Density Lipoprotein Cholesterol (LDL-C) among Patients with Ischemic Heart Disease Receiving Atorvastatin”, Health Sci J Thai, vol. 2, no. 3, pp. 26–36, Nov. 2020.